Sort
146,196 grants matching “diabetes”
Multilevel Determinants of Racial and Ethnic Disparities in Maternal Morbidity and Mortality in the Context of COVID-19 Pandemic
$886,186Xiaoming Li · University Of South Carolina At Columbia · R01 · FY2021 · AI
CCR Genomics Core
$886,180Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Epidemiology of Dementia in the Framingham Study
$886,133Philip A Wolf · Boston University Medical Campus · R01 · FY2008 · AG
Neuroimaging and Plasma Biomarkers Core
$886,119Ilya M Nasrallah · Columbia University Health Sciences · U19 · FY2022 · AG
Translational Immunology research: a support for clinical immunological research
$886,116Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2010 · AR
West Coast Metabolomics Center for Compound Identification
$886,029Oliver Fiehn · University Of California At Davis · U2C · FY2021 · ES
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti - 2
$885,886Margaret Leighton McNairy · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · HL
Epidemiology of Functional Status in Elderly Hispanics
$885,827Mary N. Haan · University Of California, San Francisco · R01 · FY2011 · AG
Determinants of the racial/ethnic disparity in MGUS risk: An epidemiologic study in 4 cohorts
$885,812Wendy Cozen · University Of California-Irvine · R01 · FY2023 · CA
PRIMARY PREVENTION TRIAL (DPT-2)
$885,811University Of New Mexico · U01 · FY2001 · DK
Biological Soft X-ray Tomography at the Advanced Light Source
$885,675Carolyn A Larabell · University Of California, San Francisco · P30 · FY2022 · GM
Genomics of glomerular disease
$885,643Krzysztof Kiryluk · Columbia University Health Sciences · RC2 · FY2020 · DK
Comprehensive Polygenic Risk Profiling Across Multiple Health Outcomes (CARDINAL)
$885,636Sally Nneoma Adebamowo · University Of Maryland Baltimore · U01 · FY2025 · HG
Novel Formulations for Injectable Growth Factors
$885,635Bruce Lamb · Affinergy ,Inc · R44 · FY2010 · DE
SBIR Phase II: Novel approach to the oral delivery of biologically active peptide analogs
$885,508Scott Shandler · Longevity Biotech, Inc · · FY2015 · TIP
Immunotherapy for Type 1 Diabetes
$885,432Francine R. Kaufman · Children'S Hospital Of Los Angeles · U01 · FY2007 · DK
Mode of action of a new Tat HIV-1 inhibitor
$885,354Susana T Valente · Scripps Florida · R01 · FY2015 · AI
DIABETES PREVENTION PROGRAM
$885,105University Of Pittsburgh At Pittsburgh · U01 · FY2001 · DK
Clinical Center for Look AHEAD: Health in Diabetes
$885,060Baylor College Of Medicine · U01 · FY2000 · DK
SMOCs: Novel Signal Transduction Complexes as New Targets for Drug Discovery
$885,001Hao Wu · Boston Children'S Hospital · DP1 · FY2015 · HD
SMOCs: Novel Signal Transduction Complexes as New Targets for Drug Discovery
$885,000Hao Wu · Boston Children'S Hospital · DP1 · FY2019 · HD
SMOCs: Novel Signal Transduction Complexes as New Targets for Drug Discovery
$885,000Hao Wu · Boston Children'S Hospital · DP1 · FY2018 · HD
SMOCs: Novel Signal Transduction Complexes as New Targets for Drug Discovery
$885,000Hao Wu · Boston Children'S Hospital · DP1 · FY2017 · HD
Lnc'ing White Fat to Brown Fat Thermogenesis
$885,000Carl D Novina · Dana-Farber Cancer Inst · DP1 · FY2020 · DK
Mouse Phenome Project
$884,995Molly A Bogue · Jackson Laboratory · R01 · FY2025 · DA